Search

Author/Creator Marconcini, R

1. 1258PBaseline predictive factors for efficacy of anti-PD1 used in first line in melanoma patients: An Italian melanoma intergroup study. (23rd October 2018)

Authors:
Marconcini, R; Tanda, E; Di Guardo, L A; Nigro, O; Fava, P; Todisco, A; Morgese, F; Cortellini, A; Stroppa, E; Gallizzi, G; Festino, L; Grego, E; Quadrini, S; Orlandini, C; Nuzzo, A; Manacorda, S; Bloise, F; Indini, A; Astrua, C; Falcone, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP). (7th November 2013)

Authors:
Ascierto, Paolo Antonio; Simeone, E; Sileni, V Chiarion; Queirolo, P; Del Vecchio, M; Di Guardo, L; Guidoboni, M; Marchetti, P; Cappellini, GC Antonini; Ferrucci, PF; Cognetti, F; Bernengo, MG; Guida, M; Marconcini, R; Mandalà, M; Cimminiello, C; Rinaldi, G; Aglietta, M; Calabrò, L; Maio, M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗